The allorejection of MSCs indicates that they are not fully immune-privileged. The authors investigated the immunogenicity of human adipose-derived MSCs and identified potential immunogenic molecules.
[Cytotherapy]
7992332
BBBBBBBB
items
1
apa
0
default
asc
1
169752
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/